MOUNTAIN VIEW, CA — (Marketwired) — 02/11/15 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will exhibit its Magellan Robotic System at the 40th Annual Society of Interventional Radiology (SIR) Scientific Meeting March 1 – March 4 at the Georgia World Congress Center in Atlanta, GA. The Company will showcase the Magellan 6Fr Robotic Catheter being used by Interventional Radiologists in embolization procedures, and will conduct Magellan Robotic System demonstrations at exhibit booth #1153.
During this year–s SIR meeting, Hansen Medical anticipates that the Magellan Robotic System will be featured in two scheduled physician presentations, one abstract, and a company sponsored breakfast symposium with five physician speakers. The Magellan Robotic System will also be highlighted in the event–s “New Product Showcase.”
The company anticipates that the following sessions during SIR will include discussion about intravascular robotics:
March 1, Session: The Future of IGI: The Case for Competencies-Based Education and Training, 1:45-2:00pm, Room 311
How will I teach IR in 2015? – Constantino Peña, MD (Miami Cardiac & Vascular Institute, Miami, FL)
March 2, Session: Emerging Concepts, 5:10 – 5:20pm, Room 314
Robot assisted transarterial chemoembolization for hepatocellular carcinoma: initial evaluation of safety, feasibility, success and outcomes using Magellan system – Sandeep Rao, MD (Sierra Providence Health Network, El Paso, TX)
The following abstract is also scheduled to be included in the poster session:
Abstract #353: Evaluation of robot-assisted catheterization using the Magellan system for embolization – Gautam Rao (Fort Worth, TX), Sandeep Rao, MD (El Paso, TX)
Hansen Medical is also sponsoring a breakfast symposium on Tuesday, March 2 from 7:00 – 8:00am called “Robotic Embolization: What You Need to Know.” This session will take place in the Omni CNN Center, International Ballroom A – M2 – North Tower. RSVP by email to . The following topics will be covered:
Introduction to Intravascular Robotics – Barry Katzen, MD (Miami, FL, USA)
Robotic UFE & TACE – Marc Sapoval, MD, PhD (Paris, France)
PAE and Role for Robotics – Sandeep Bagla, MD (Alexandria, VA, USA)
Radiation Protection – Sandeep Rao, MD (El Paso, TX, USA)
Integrating Robotics into IR Practice – Keith Sterling, MD (Alexandria, VA, USA)
“We are excited to see many Magellan physician users share their experiences with robotic embolization at one of the year–s most important global Interventional Radiology meetings,” said Cary Vance, Hansen Medical–s President and Chief Executive Officer. “Embolization procedures address broad procedural categories, including Women–s Health, Men–s Health, and Cancer treatment. Magellan enables patients to benefit from robotic precision, control and stability during these procedures performed in very small blood vessels, while also addressing radiation exposure and other key occupational hazards for physicians and staff.”
Hansen Medical–s Magellan Robotic System is intended to be used to facilitate navigation in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. The Magellan Robotic System is designed to deliver predictability, control and catheter stability to endovascular procedures. Since its commercial introduction in the U.S. and Europe, the Magellan Robotic System has demonstrated its clinical versatility in many cases in a broad variety of peripheral vascular procedure types in centers across the U.S. and Europe. The Magellan Robotic System offers several important features including:
Provides predictability, control and catheter stability as a physician navigates a patient–s peripheral vasculature and then provides a conduit for manual treatment of vascular disease with standard therapeutic devices.
Is designed to enable more predictable procedure times and increased case throughput potentially allowing hospitals to improve utilization within their vascular business line
Employs an open architecture designed to allow for the subsequent use of many therapeutic devices on the market today.
Is designed to potentially reduce physician radiation exposure and fatigue by allowing the physician to navigate procedures while seated comfortably at a remote workstation away from the radiation field and without wearing heavy lead as required in conventional endovascular procedures.
The Magellan 9Fr Robotic Catheter allows for independent, robotic control of the distal tip of two telescoping catheters (an outer Guide and an inner Leader catheter), as well as robotic manipulation of standard guide wires.
The Magellan 6Fr Robotic Catheter allows for independent robotic control of two separate bend sites on a single catheter, as well as robotic manipulation of standard guide wires. This smaller catheter design may be preferred by certain physicians who prefer a smaller diameter vessel access site, or in procedures in smaller vessels.
Hansen Medical, Inc., based in Mountain View, California, is a global leader in Intravascular Robotics, developing products and technology designed to enable the accurate positioning, manipulation and control of catheters and catheter-based technologies. The Company–s Magellan Robotic System, 9Fr Magellan Robotic Catheter, Magellan 6Fr Robotic Catheter, and related accessories are intended to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. The Company–s mission is to enable Cardiac Arrhythmia and Endovascular Procedures and to improve patient outcomes through the use of Intravascular Robotics. Additional information can be found at .
“Artisan Extend,” “Hansen Medical,” “Hansen Medical (with Heart Design),” “Heart Design (Logo),” “Sensei,” “Lynx,” “Artisan,” “Instinctive Motion,” “Fine Force Technology,” “IntelliSense” are registered trademarks, and “Magellan” and “Hansen Medical Magellan” are trademarks of Hansen Medical, Inc. in the U.S. and other countries.
You must be logged in to post a comment Login